Labsystems Diagnostics’ Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT).
Benefits
- First Neonatal Toxoplasma screening test in the world
- Quantitative results
- Clinically proven performance
- High sensitive µ-capture test
Specification
- Neonatal Toxoplasma gondii IgM FEIA, 5 strip plates (12×8), 480 wells 61 99 802